Results
|
5541.
|
|
|
5542.
|
|
|
5543.
|
HER2, TOP2A, and TIMP-1 and responsiveness to adjuvant anthracycline-containing chemotherapy in high-risk breast cancer patients. [electronic resource] by
- Ejlertsen, Bent
- Jensen, Maj-Britt
- Nielsen, Kirsten V
- Balslev, Eva
- Rasmussen, Birgitte B
- Willemoe, Gro L
- Hertel, Pernille B
- Knoop, Ann S
- Mouridsen, Henning T
- Brünner, Nils
Producer: 20100323
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
5544.
|
|
|
5545.
|
|
|
5546.
|
|
|
5547.
|
|
|
5548.
|
|
|
5549.
|
|
|
5550.
|
|
|
5551.
|
TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients. [electronic resource] by
- Hertel, Pernille Braemer
- Tu, Dongsheng
- Ejlertsen, Bent
- Jensen, Maj-Britt
- Balslev, Eva
- Jiang, Shan
- O'Malley, Frances P
- Pritchard, Kathleen I
- Shepherd, Lois E
- Bartels, Annette
- Brünner, Nils
- Nielsen, Torsten O
Producer: 20120522
In:
Breast cancer research and treatment vol. 132
Availability: No items available.
|
|
5552.
|
|
|
5553.
|
|
|
5554.
|
|
|
5555.
|
|
|
5556.
|
|
|
5557.
|
|
|
5558.
|
|
|
5559.
|
|
|
5560.
|
|